EPO Patents = 2

Trademarks = 3

Forward Citations = 7

Loading Chart...

4 inventors (with patents filed for the assignee):

Paul Olson (5 out of 24 patents)

Don W Moss (4 out of 4 patents)

Nicholas Staten (3 out of 3 patents)

4. Alfred Kim (1 out of 1 patent)

5. Donald W Moss (0 patent)

6. Nick Staten (0 patent)

7. Donald Moss (0 patent)

5 patents: Sort by Forward Citations

1. 11029318 - Methods for predicting and treating patients with increased risk of adverse pregnancy outcome (2021-06-08),

2. 9939446 - Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders (2018-04-10),

3. 9182396 - Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders (2015-11-10),

4. 9164088 - Detecting complement activation (2015-10-20),

5. 8865164 - Detecting complement activation (2014-10-21),

Kypha, Inc. is a biotechnology company focused on developing innovative immune diagnostic products for inflammatory diseases. Their solutions help clinicians make more informed treatment decisions and improve patient outcomes. With a strong commitment to research and development, Kypha is dedicated to advancing the field of immune diagnostics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

5 Patents

#266 in St. Louis, MO

#694 in Missouri

#50,171 in US

St. Louis, MO, United States of America

Kypha, Inc.